COVID-HIGIV

COVID-19 hyperimmune globulin · Emergent BioSolutions

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for COVID-HIGIV, covering 2023-02-02 to 2023-02-02. Get the full timeline:

Most recent: Clinical Trial Update: A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults [Phase 1]